Electroencephalographic Power Spectral Density Profile of the Orexin Receptor Antagonist Suvorexant in Patients with Primary Insomnia and Healthy Subjects

STUDY OBJECTIVES: Suvorexant, an orexin receptor antagonist, improves sleep in healthy subjects (HS) and patients with insomnia. We compared the electroencephalographic (EEG) power spectral density (PSD) profile of suvorexant with placebo using data from a phase 2 trial in patients with insomnia. We...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Ma, Junshui, Svetnik, Vladimir, Snyder, Ellen, Lines, Christopher, Roth, Thomas, Herring, W. Joseph
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Associated Professional Sleep Societies, LLC 2014
Konular:
EEG Power Spectral Density of the Orexin Receptor Antagonist Suvorexant
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4173918/
https://ncbi.nlm.nih.gov/pubmed/25197807
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5665/sleep.4068
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller